Actively Recruiting
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer
Led by Seoul National University Hospital · Updated on 2023-06-27
108
Participants Needed
1
Research Sites
257 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the incidence of low anterior resection syndrome and quality of life after cytoreductive surgery for advanced ovarian cancer patients.
CONDITIONS
Official Title
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal carcinomatosis planning cytoreductive surgery or secondary surgery after chemotherapy
- Suspected tumor invasion in pelvic cavity or rectosigmoid colon requiring tumor removal with clinical FIGO stage IIIB or higher
- ECOG performance status between 0 and 2
- Age 18 years or older
You will not qualify if you...
- Previous low anterior resection surgery
- History of gastrointestinal cancer other than ovarian cancer
- Have a colostomy
- Prior radiation treatment to abdominal or pelvic area
- ECOG performance status higher than 3
- Taking opioid pain medications
- Intellectual disability or dementia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea, 03080
Actively Recruiting
Research Team
S
Soo Jin Park, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here